Premium
Evidence‐based treatment for gynoid lipodystrophy: A review of the recent literature
Author(s) -
Pérez Atamoros Francisco M.,
Alcalá Pérez Daniel,
Asz Sigall Daniel,
Ávila Romay Alfonsina A.,
Barba Gastelum José A.,
Peña Salcedo José A.,
Escalante Salgado Pablo E.,
Gallardo Palacios Guillermo J.,
GuerreroGonzalez Guillermo A.,
Morales De la Cerda Rodrigo,
Ponce Olivera Rosa María,
Rossano Soriano Fabiola,
Solís Tinoco Eduardo,
Welsh Hernández Esperanza C.
Publication year - 2018
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.12555
Subject(s) - lipodystrophy , dermatology , medicine , quality of life (healthcare) , clinical practice , cellulite , intensive care medicine , physical therapy , cellulitis , immunology , nursing , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy
Summary Gynoid lipodystrophy ( GLD ) is a structural, inflammatory, and biochemical disorder of the subcutaneous tissue causing alterations in the topography of the skin. Commonly known as “cellulite,” GLD affects up to 90% of women, practically in all stages of the life cycle, beginning in puberty. It is a clinical condition that considerably affects the patients’ quality of life. It is a frequent reason for consultation, although the patients resort to empirical, improvised, nonevidence‐based treatments which discourage and can be a source of frustration not only because of the lack of results but also due to the complications derived from those treatments. In this article, a panel of experts from different specialties involved in the management of this clinical skin disorder presents the results of a systematic literature search and of the consensus discussion of the evidence obtained from different treatments currently available. The analysis was divided into topical, systemic, noninvasive, and minimally invasive treatments.